top of page
Overview

Overview

new logo.png

COVID-19 Health Declaration

INTRODUCTION

As COVID restrictions continue to lift, businesses have engaged in a COVID risk assessment process, establishing workplace hazards and potential of exposure to COVID. The assessment identifies control measures for specific tasks, travel, adopting current government guidance and requirements ensuring they are providing a COVID secure workspace for their staff / crew and any other persons that may be affected.

​

Part of the COVID secure process will involve obtaining a health declaration from staff, or third parties that may be visiting site. This declaration seeks to confirm employees/site visitors, or anyone in their household are not showing any symptoms of COVID-19 before they are permitted on site. 

​

​

ABOUT THE DECLARATION

This declaration will outline key symptoms of COVID-19 and ask you to confirm you are not showing any of these, nor anyone in your household. In addition, if you are classed as a clinically extremely vulnerable person you should declare this in the relevant question. If you are unsure, please click here

The form will also ask you to confirm that you agree to your details being submitted and held by this system. 

​

Your details are held securely for the purpose of the health declaration only. Your details will not be shared with anyone outside of your employer or ESS. 

​

Once confirmation is provided to your employer, all details are removed from the system. If you have any concerns, please contact either your employer directly or our office info@ess-consultants.co.uk. To continue with the declaration, please select the button below. 

​

​

​

Clinically VPs

CLINICALLY EXTREMELY VULNERABLE PEOPLE

Clinically extremely vulnerable people may include the following people. Disease severity, history or treatment levels will also affect who is in this group.

  1. Solid organ transplant recipients.

  2. People with specific cancers:

    • people with cancer who are undergoing active chemotherapy

    • people with lung cancer who are undergoing radical radiotherapy

    • people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment

    • people having immunotherapy or other continuing antibody treatments for cancer

    • people having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors

    • people who have had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs

  3. People with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary (COPD).

  4. People with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell).

  5. People on immunosuppression therapies sufficient to significantly increase risk of infection.

  6. Women who are pregnant with significant heart disease, congenital or acquired.

  7. Adults with Down's syndrome.

  8. Adults on dialysis or with stage 5 chronic kidney disease

  9. High risk individuals who now require to shield, based on health assessment inc age, ethnicity, deprivation (based on postcode), weight (body mass index), some types of underlying health issues, some prescribed medications. This group will receive a letter from their GP explaining why and confirming they need to shield. 

 

 

People in this group should have been contacted to tell them they are clinically extremely vulnerable.

If you are still concerned, you should discuss your concerns with your GP or hospital clinician.

bottom of page